<!DOCTYPE html>
<html>
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" type="text/css" href="css/style-manual.css">
    <link rel="stylesheet" href="https://www.w3schools.com/w3css/4/w3.css">
    <script src="js/script.js"></script>
</head>
<body>
<!--L- Amlo-------------------------------------------------------->
<div class="bodyDiv" id="idL- Amlo">
    <div class="w3-container w3-center w3-animate-left">
        <h2 class="mango">L- Amlo</h2>
    </div>
<b>Product Orientation & Presentation:</b><br>
<table class="table1">
 <tr>
    <th>Brand Name:</th>
    <th>L-Amlo.</th>
  </tr>

  <tr>
 
    <td>Generic & Strength:</td>
	<td>Levamlodipine Maleate INN.<br>
   L-Amlo 1.25 Tablet: Each tablet contains Levamlodipine Maleate INN equivalent to Levamlodipine 1.25 mg. <br>
   L-Amlo 2.5 Tablet: Each tablet contains Levamlodipine Maleate INN equivalent to Levamlodipine 2.5 mg. <br>
 L-Amlo 5 Tablet: Each tablet contains Levamlodipine Maleate INN equivalent to Levamlodipine 5 mg.
</td>
    
  </tr>
  
  <tr>
    <td>Dosage Form:</td>
    <td>Tablet</td>
    
  </tr>
	 
  <tr>
    <td>Therapeutic Class:</td>
	<td>Antihypertensive</td>
    
    </tr>

   
  </tr>
	 
  <tr>
    <td>Sub Therapeutic class: </td>
	<td>--</td>
    
    </tr>
		
  
  <tr>
    <td>Commercial Pack:</td>
	<td>L-Amlo 1.25 Tablet: 30’s<br>
	L-Amlo 2.5 Tablet: 30’s<br>
	L-Amlo 5 Tablet: 30’s
	</td>
    
  </tr>
	 
   <tr>
    <td>Price (TP):</td>
    <td>1.25mg= 4 Tk./Tablet,<br>
	2.5mg= 7 Tk./Tablet, <br>
	5mg= 9 Tk./Tablet
	</td>
	
   </tr>	
	 
   <tr>
 
    <td>Flavour </td>
    <td>--</td>
	 
  </tr>
  
  <tr>
 
    <td>Indication </td>
    <td>Hypertension</td>
	 
  </tr>
  <tr>
<td>Pregnancy: 
</td>
<td>
(Pregnancy category- C)The limited available data on amlodipine use in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. Hypertension increases the fetal risk for intrauterine growth restriction and intrauterine death. Pregnant women with hypertension should be carefully monitored and managed accordingly by physician. 
</td>
</tr>
<tr>
<td>Lactation: 
</td>
<td>
(Not recommended)
No adverse effects of amlodipine on the breastfed infant have been observed. There is no available information on the effects of amlodipine on milk production.
</td>
</tr>
<tr>
 
<td>Children: </td>
<td>
L-Amlo (1.25 to 2.5 mg daily) is effective in lowering blood pressure in patients 6 to 17 years. Effect of L-Amlo on blood pressure in patients less than 6 years of age is not known.
</td>
</tr>
  
   <tr>
 
    <td>Brand Name Justification: </td>
    <td><b>L</b>ev<b>amlo</b>dipine= L-Amlo </td>
	 
  </tr>
  
 <tr>
<td>Dosage & Administration: 
</td>
<td>
<li>Adult recommended dose:</li> 2.5 mg orally once daily with maximum dose 5 mg once daily. 
<li>For small, fragile or elderly patients or patients with hepatic insufficiency:</li> 1.25 mg once daily starting dose is recommended.
<li>Paediatric starting dose:</li> 1.25 mg to 2.5 mg once daily or as directed by the physicians.
</td>
</tr>
<tr>
<td>Key Selling Points: 
</td>
<td>
<li>L-Amlo confirms negligible oedema compared to conventional Amlodipine</li>
<li>L-Amlo shows better efficacy at half dose</li>
<li>L-Amlo ensures better patients compliance due to less side effects</li>
</td>
</tr>
<tr>
<td>Target Doctor: 
</td>
<td>
<li>Cardiologists</li>
<li>Medicine Specialists</li>
<li>Nephrologist</li>
<li>Diabetologists</li>
<li>Neurologist</li>
<li>GPs</li>

</td>
</tr>
<tr>
<td>Side effects: 
</td>
<td>
<li>Tiredness</li>
<li>Nausea</li>
<li>Stomach pain</li>
<li>Dizziness</li>
<li>Flushing (hot or warm feeling in face)</li>
<li>Heart palpitations (very fast heartbeat)</li>
</td>
</tr>
<tr>
<td colspan="4">
<table class="table2">
<thead>
<tr>
<th></th>
<th>Mode of action:</th>
</tr>
</thead>
<tbody>
<tr>
<td></td>
<td>Ca<sup>2+</sup> entry thorough L-type Ca<sup>2+</sup> channels into vascular smooth muscle
</tr>
<tr>
<td>L-Amlo &#9587; Ca<sup>2+</sup> entry --------></td>
<td>&#8681;</td>
</tr>
<tr>
<td>
</td>
<td>
No Calcium Calmodulin complex
</td>
</tr>
<tr>
<td>
</td>
<td>&#8681;
</td>
</tr>
<tr>
<td>
</td>
<td>
Leads to decreased Peripheral vascular resistance
</td>
</tr>
<tr>
<td>
</td>
<td>&#8681;
</td>
</tr>
<tr>
<td>
</td>
<td>
Causes vasodilation
</td>
</tr>
<tr>
<td>
</td>
<td>&#8681;
</td>
</tr>
<tr>
<td>
</td>
<td>
Ensures a subsequent decrease in blood pressure
</td>
</tr>
<tr>
<td>
</td>
<td>&#8681;
</td>
</tr>
<tr>
<td>
</td>
<td>Manages Hypertension
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</table>
<br><br>

<table class="table2">
<thead>
<tr>
<th>Hypertension Process:
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ca<sup>2+</sup> entry thorough L-type Ca<sup>2+</sup> channels into vascular smooth muscle
</tr>
<tr>
<td>&#8681;
</td>
</tr>
<tr>
<td>
Intracellular Ca<sup>2+</sup> Calmodulin
</td>
</tr>
<tr>
<td>&#8681;
</td>
</tr>
<tr>
<td>
Calmodulin-Calmodulin complex
</td>
</tr>
<tr>
<td>&#8681;
</td>
</tr>
<tr>
<td>
Activation of myosin light chain kinase
</td>
</tr>
<tr>
<td>&#8681;
</td>
</tr>
<tr>
<td>Phosphorylation of myosin
</td>
</tr>
<tr>
<td>&#8681;
</td>
</tr>
<tr>
<td>Activation of myosin ATPase
</td>
</tr><tr>
<td>&#8681;
</td>
</tr>
<tr>
<td>Muscular contraction
</td>
</tr>
<tr>
<td>&#8681;
</td>
</tr>
<tr>
<td>Increased Peripheral vascular resistance
</td>
</tr>
<tr>
<td>&#8681;
</td>
</tr>
<tr>
<td>Causes Hypertension
</td>
</tr>
</tbody>
</table>
<br><br>


<strong>Short Detailing and Possible Q& A of L-Amlo</strong><br>
Dear Sir/Madam:<br>
Good Morning/Evening!<br>
In your everyday practice, you are giving treatment to many hypertensive patients.<br>
তাদের জন্য আপনি first-line therapy হিসেবে usually Amlodipine prescribe করে থাকেন। তবে Amlodipine <br>
একটি বহুল ব্যবহৃত ড্রাগ হলেও pedal oedema’র কারণে এর patient compliance very poor.<br>
এই সমস্যা বিবেচনা করে, Navana has launched L-Amlo যা Levamlodipine 1.25, 2.5 & 5 mg এর preparations.<br>
Levamlodipine, এটি S-Amlodipine নামেও পরিচিত। Racemic Amlodipine এর দুটি এনানশিওমার (R & S) এর মধ্যে শুধুমাত্র <br>
S-enantiomer (pure Amlodipine), L-type calcium channel কে ব্লক করে, যা maximum therapeutic efficacy<br>
 এর পাশাপাশি peripheral oedema প্রায় করেনা বললেই চলে,যা    highest patients’ compliance নিশ্চিত করে। Levamlodipine<br>
 হচ্ছে pure Amlodipine যা L- type calcium channel ব্লক করে vasodilation করে এবং hypertension নিয়ন্ত্রণ করে। <br>
Racemic Amlodipine এর R-enantiomer pedal oedema করার জন্য দায়ী কিন্তু  Levamlodipine, pure Amlodipine<br>
হওয়ার কারণে শুধুমাত্র therapeutic effect দেয় এবং কোনো প্রকার pedal oedema করেনা। পাশাপাশি Racemic Amlodipine এর চেয়ে <br>
half-dose এ L-Amlo better efficacy show করে।<br><br>

Dear স্যার/ম্যাডাম, আশা করি patient compliance এর কথা বিবেচনা করে hypertensive patients এর জন্য নাভানার <br>
L-Amlo prescribe করবেন।<br>
Thank you Sir/Madam! <br><br>


Short detailing of L-Amlo<br>
Almost No Pedal Oedema with L-Amlo.<br>
1st time in Bangladesh L-Amlo<br>
Levamlodipine 1.25, 2.5 & 5 mg Tablet<br>
Dear Sir/Madam:<br>
Good Morning/Evening!<br>
In your everyday practice, you are giving treatment to many hypertensive patients. তাদের জন্য আপনি first-line therapy হিসেবে usually Amlodipine prescribe করে থাকেন। তবে Amlodipine একটি বহুল ব্যবহৃত ড্রাগ হলেও pedal oedema'র কারণে এর patient compliance very poor.<br> 
L-Amlo&#x261E;Purified হওয়ার কারণে শুধুমাত্র therapeutic effect দেয় এবং কোনো প্রকার pedal edema করে না।<br>
Shows Better Efficacy&#x261E; Racemic Amlodipine half dose এ better efficacy show করে।<br>
Navana Pharma সব সময় affordable price এ highest quality ensure করে থাকে।<br>
Sir/Madam,<br>
আশা করি patient compliance এর কথা বিবেচনা করে hypertensive patients এর জন্য নাভানা ফার্মার L-Amlo prescribe করবেন ।<br>
Thank you Sir/Madam!<br><br>

<strong>Possible questions from Doctors:</strong> <br><br>

Doctor: <strong>L- Amlo এবং amlodipine এর পার্থক্য কি?</strong><br><br>
MPI: Thank you Sir for your query. L-Amlo হচ্ছে Levamlodipine এরপ্রিপারেশন। Levamlodipine, S-Amlodipine<br>
নামেও পরিচিত। আপনি জানেন যে, Levamlodipine হচ্ছে pure Amlodipine যা L- type calcium channel ব্লক করে vasodilation<br>
করে এবং hypertension নিয়ন্ত্রণ করে। অন্যদিকে Racemic Amlodipine এর দুটি এনানশিওমার (R & S) এর মধ্যে R-enantiomer কোনো প্রকার <br>
therapeutic effect দেয়না বরং pedal oedema করার জন্য দায়ী। অর্থাৎ বলা যেতে পারে, L- Amlo শুধুমাত্র ভালো ইফেক্ট দিচ্ছে যেখানে Amlodipine,<br>
therapeutic effect এর সাথে adverse effect ও দিচ্ছে।<br><br>

Doctor: <strong>Amlodipine, R-Enantiomer এর মাধ্যমে নাইট্রিক অক্সাইড উৎপাদন করে এবং পাশাপাশি ক্যালশিয়াম চ্যানেলকেও ব্লক করে। অন্যদিকে  Levamlodipin<br>
শুধু Ca channel কে block করে HTN কমায়, সেদিক বিবেচনা করলে amlodipine এর efficacy বেশি হবার কথা, যদি না হয় তবে কেন?</strong><br><br>
MPI: Sir,আপনি জানেন যে, Amlodipine এর মধ্যে S-Amlodipine, therapeutic effect দেয় এবং R-Amlodipine, Nitric oxide <br>
উৎপাদনের মাধ্যমে pedal oedema করে। আমরা জানি, নাইট্রিক অক্সাইড ভেসোডাইলেটর হিসেবে কাজ করে এবং ব্লাড প্রেসার কমাতে ভুমিকা রাখে। কিন্তু Amlodipine, <br>
যেই পরিমাণ নাইট্রিক অক্সাইড উৎপাদন করে তা ব্লাড প্রেসার কমানোর জন্য যথেষ্ট নয় । তাই মুলত ব্লাড প্রেসার কমানোর কাজটি , S-Amlodipine ই করে থাকে। নাইট্রিক অক্সাইড <br>
এখানে কোনো ভুমিকা রাখেনা।<br><br>

Doctor: <strong>L-Amlo এর half-life কত?</strong><br><br>
MPI: Sir, L-Amlo এর half-life অনেকটা Amlodipine এর half-life এর কাছাকাছি, 30-50 hrs.<br><br>

Doctor: <strong>L-Amlo এর এত বেশি half-life হলে কি special কোন benefit পাওয়া যাবে? Dose এর ক্ষেত্রে কি extra কোন advantage পাওয়া যাবে?</strong><br>
MPI: Sir, আপনি জানেন, কিছু কিছু anti-hypertensive drug এর half-life কম। যার কারনে লম্বা সময় ধরে এর ইফেক্ট থাকেনা এবং ব্লাড প্রেশার <br>
fluctuate করে। যেহেতু L-Amlo এর half-life বেশি তাই, এটি লম্বা সময় ধরে রোগীর প্রেশারকে স্থিতিশীল রাখতে সাহায্য করে। <br><br>

Doctor: <strong>Dose এর ক্ষেত্রে কি extra কোন advantage পাওয়া যাবে?</strong><br><br>
MPI: যেহেতু half-life বেশি, তাই once daily dose’ই L-Amlo high blood pressure কে নরমালাইজ করবে। <br><br>

Doctor: <strong>অন্যান্য anti hypertensive এর সাথে adjuvant therapy হিসেবে দেয়া যাবে?</strong><br><br>
MPI: জী স্যার। Amlodipine যেসব anti hypertensive এর সাথে adjuvant therapy হিসেবে দেয়া যায়, L-Amlo ও তাদের সাথে দেওয়া যাবে।<br><br>

Doctor: <strong>Pregnancy ও lactation এ দেয়া যাবে?</strong><br><br>
MPi: No Sir, Pregnancy & Lactation এ L-Amlo দেওয়া যাবেনা। <br><br>

Doctor: <strong>৬০ ঊর্ধ রোগীদের ক্ষেত্রে L-Amlo minimum কত dose থেকে শুরু করতে হবে?</strong><br><br>
MPI: বয়স্ক রোগীদের ক্ষেত্রে starting dose 1.25 mg যা maximum 2.5 mg পর্যন্ত হবে।<br><br>

Doctor: <strong>Levamlodipin maleate আর Levamlodipin besylate/ S-Amlodipine besylate এর মধ্যে কোনটি ভালো?</strong><br><br>
MPI: যদিও Levamlodipine এর সাথে দুটি ই সল্ট/লবন হিসেবে থাকে, এর মধ্যে Maleate বেশি half-life show করে। পাশাপাশি এর Area under curve<br>
ও বেশি। যার কারনে systemic exposure বেশি হয় ও better efficacy show করে। এছাড়া Levamlodipine এর সাথে Maleate form <br>
FDA approved কিন্তু Levamlodipine or S-Amlodipine এর সাথে Besylate FDA approved নয়।<br><br>

Doctor : <strong>Cilnidipine ও pedal oedema করেনা এবং এর efficacy ও ভালো। তাহলে L-Amlo থেকে cilnidipine কে কি ভালো বলা যেতে পারে?</strong><br>
MPI: Sir, আপনি ঠিক বলেছেন। কিন্তু বিভিন্ন research studies দেখিয়েছে যে, L-Amlo এবং  Cilnidipine similar efficacy show <br>
করে এবং দুটি ই pedal edema করেনা। কিন্তু Cilnidipine এর half life 2-2.5 hrs তাই এর effect কম সময় ধরে থাকে কিন্তু L-AMlo <br>
এর half-life বেশি হওয়ার জন্য এটি লম্বা সময় ধরে ব্লাড প্রেশারকে নিয়ন্ত্রন করতে পারে। তাই আমরা বলতে পারি, patients’ compliance এর ক্ষেত্রে L-Amlo,<br>
Cilnidipine থেকে ভালো।<br><br>

Doctor: <strong>L-Amlo’র serious side effect কি হতে পারে?</strong><br><br>
MPI: L-Amlo, যেসব রোগীর severe aortic stenosis আছে, তাদের ক্ষেত্রে hypotension করতে পারে। <br><br>

<strong>How does CCB cause edema?</strong><br><br>

CCB-induced oedema is caused primarily by the increased capillary hydrostatic pressure(outward driving <br>
force) that results from greater dilation of pre-capillary than post-capillary vessels<br><br>

In pedal edema it is not due to the retention of sodium and water. But it is the more dialation <br>
of the arterioles before the capillary network than the arterioles after the capillary network. <br>
There is more dialation of the precapillary network than the postcapillary network. Arterioles <br>
dialation is deferent. The arterioles dialation before the capillary network is higher than the after <br>
capillary network. After capillary network, it is less. That is why fluid accumulate at the place(cell).<br><br>

Doctor: Thank you.<br>
MPI: Welcome Sir.<br><br>
	
ently Asked Questions (FAQ)<br>
Can L-Amlo (Levamlodipine) be given as a first line therapy to treat hypertension?<br>
Yes. According to joint National Committee (INC-8), L-Amlo (Levamlodipine) can be given as a first line
therapy to treat hypertension.<br><br>

What are the two main types of hypertension?<br>
There are two main types of high blood pressure:<br>
Primary and Secondary high blood pressure.<br>
Primary, or essential, high blood pressure is the most common type of high blood pressure.<br>
Secondary high blood pressure is caused by another medical condition or use of certain medicines.<br><br>

Can L-Amlo be prescribed to paediatric patients?<br>
L-Amlo is a prescription drug and antihypertensive agent. It can be prescribed to the patients 6 years of
age and older.<br><br>

What are the categories of blood pressure?<br>
According to the new ACC and American Heart Association (AHA) guidelines blood pressure categories
are:<br>
Normal: Less than 120/80 mm Hg;<br>
Elevated: Systolic between 120-129 and diastolic less than 80;<br>
Stage 1: Systolic between 130-139 or diastolic between 80-89;<br>
Stage 2: Systolic at least 140 or diastolic at least 90 mm Hg;<br>
Hypertensive crisis: Systolic over 180 and/or diastolic over 120, with patients needing prompt changes in
medication if there are no other indications of problems, or immediate hospitalization if there are signs of
organ damage.<br><br>

Can L-Amlo be given as combination with other anti-hypertensive agents?<br>
Yes, L-Amlo can be given as both monotherapy and as a combination with other anti-hypertensive agents.<br><br>

What are the most common side effects of L-Amlo?<br>
Tiredness<br>
Nausea<br>
Stomach pain<br>
Dizziness<br>
Flushing (hot or warm feeling in face)<br>
Heart palpitations (very fast heartbeat)<br><br>

What could be the serious side effects of L-Amlo?<br>
Low blood pressure (hypotension). L-Amlo may cause low blood pressure, especially in people that have
a condition called severe aortic stenosis.<br>
Worsening chest pain (angina) or heart attack. L-Amlo may cause worsening chest pain or heart attack
after starting or increasing the dose, especially in people with a condition called severe obstructive
coronary artery disease.<br><br>

Why does not Levamlodipine cause peripheral oedema?<br>
As Levamlodipine does not have any R-enantiomer, it does not cause peripheral oedema. Because, in
racemic Amlodipine, the R-enantiomer is the part, responsible for causing peripheral oedema.<br><br>

Is Cilnidipine better than Levamlodipine?<br>
Cilinidipine is the 4th generation CCBs but different studies showed that Levamlodipine 2.5 mg is
compared with Cilnidipine 10 mg where Levmlodipine was found to normalize high blood pressure better
than Cilnidipine. Besides, Cilnidipine 10 mg is 9 tk./Tablet whereas L-Amlo 2.5 mg is 7 tk./tablet. So with
one fourth dose, L-Amlo shows better efficacy and does not cause peripheral oedema as well as gives
price benefit to the patients compared to Cilnidipine.<br><br>

What is the pregnancy category of Levamlodipine?<br>
Levamlodipine pregnancy category "C"<br><br>

Can L-Amlo be used while pregnant or breastfeeding?<br>
Pregnant women: The limited available data on Amlodipine use in pregnant women are not sufficient to
inform a drug-associated risk for major birth defects and miscarriage.<br>
Lactation: No adverse effects of Amlodipine on the breastfeeding infant have been observed.<br><br>

www.conjupri.com<br>
www.heart.org<br><br>

	
	
<li><strong>Abridged Prescribing Information</strong></li>
<li><b>Composition:</b></li> 
L-Amlo 1.25 Tablet: Each tablet contains Levamlodipine Maleate INN equivalent to Levamlodipine 1.25 mg. L-Amlo 2.5 Tablet: Each tablet contains Levamlodipine Maleate INN equivalent to Levamlodipine 2.5 mg. <br>
L-Amlo 5 Tablet: Each tablet contains Levamlodipine Maleate INN equivalent to Levamlodipine 5 mg. 
<li><b>Pharmacology:</b></li> Levamlodipine, also known as S-Amlodipine, is a pharmacologically active enantiomer of Amlodipine and an antihypertensive medication. Levamlodipine belongs to the dihydropyridine group of calcium channel blockers. It blocks the transmembrane influx of calcium through L-type calcium channels into the vascular and cardiac smooth muscles resulting in vasodilation and a decrease in blood pressure. It inhibits calcium influx in vascular smooth muscle to a greater degree than in cardiac muscle, leading to decreased peripheral vascular resistance and lowered blood pressure. Indication: L-Amlo is a calcium channel blocker which is used alone or in combination with other antihypertensive agents for the treatment of hypertension. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.<br>
<li><b>Dose & Administration:</b></li>
<li>Adult recommended dose:</li> 2.5 mg orally once daily with maximum dose 5 mg once daily. For small, fragile or elderly patients or patients with hepatic insufficiency, 1.25 mg once daily starting dose is recommended.
<li>Paediatric starting dose:</li>
1.25 mg to 2.5 mg once daily or as directed by the physicians.
<li><b>Contraindication:</b></li>
Levamlodipine is contraindicated in patients with known sensitivity to Amlodipine. 
<li><b>Warning & Precaution:</b></li>
Symptomatic hypotension is possible, particularly in patients with severe aortic stenosis. However, acute hypotension is unlikely.Worsening angina and acute myocardial infarction can develop after starting or increasing the dose of Amlodipine, particularly in patients with severe obstructive coronary artery disease. The dose should be titrated slowly in patients with severe hepatic impairment. Side Effects: The most common side effects of Levamlodipine include swelling of legs or ankles, tiredness, nausea, stomach pain, sleepiness, dizziness, flushing (hot or warm feeling in face), heart palpitations (very fast heartbeat). Levamlodipine may cause serious side effects, including low blood pressure (hypotension). 
<li><b>Use In Pregnancy & Lactation:</b></li>
<li>Pregnancy:</li>
The limited available data on amlodipine use in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. Hypertension increases the fetal risk for intrauterine growth restriction and intrauterine death. Pregnant women with hypertension should be carefully monitored and managed accordingly by physician.
<li><b>Lactation:</b></li>
No adverse effects of amlodipine on the breastfed infant have been observed. There is no available information on the effects of amlodipine on milk production. 
<li><b>Use In Children & Adolescents:</b></li>
L-Amlo (1.25 to 2.5 mg daily) is effective in lowering blood pressure in patients 6 to 17 years. Effect of L-Amlo on blood pressure in patients less than 6 years of age is not known.
<li><b>Drug Interaction:</b></li>
Impact of Other Drugs on Amlodipine.<br>
DrugCYP3A Inhibitors:<br>
Co-administration with CYP3A inhibitors results in increased systemic exposure to Amlodipine and may require dose reduction. Symptoms of hypotension and edema should also be monitored to determine the need for dose adjustment.<br>
CYP3A Inducers:<br>
No information is available on the effects of CYP3A inducers on Amlodipine. Blood pressure should be closely monitored when Amlodipine is co-administered with CYP3A inducers. Sildenafil: Hypotension should be monitored when Sildenafil is co-administered with Amlodipine.<br>
Impact of Amlodipine on Other Drugs.<br>
Simvastatin:<br>
Co-administration of Simvastatin with Amlodipine increases the systemic exposure of Simvastatin. Dose of Simvastatin in patients on Amlodipine should be limited to 20 mg daily.<br>
Immunosuppressants:<br>
Amlodipine may increase the systemic exposure of Cyclosporine or Tacrolimus when co-administered. Frequent monitoring of
trough blood levels of Cyclosporine and Tacrolimus is recommended and the dose should be adjusted when appropriate. Overdose: Over dosage might be expected to cause excessive peripheral vasodilation with marked hypotension and possibly a reflex tachycardia. In humans, experience with intentional over dosage of amlodipine is limited. Active cardiac and respiratory monitoring should be initiated, if massive overdose occurs.
<li><b>Storage:</b></li>
Store below 30°C. away from light and in a dry place. Keep out of the reach of children.
<li><b>Packing:</b></li>
L-Amlo 1.25 Tablet: Each box contains 3 x 10 tablets in Alu-Alu blister pack & an insert. L-Amlo 2.5 Tablet: Each box contains 3 x 10 tablets in Alu-Alu blister pack & an insert. L-Amlo 5 Tablet: Each box contains 3 x 10 tablets in Alu-Alu blister pack & an insert.
<br>

<div class="link-btn" onclick="window.open('https://drive.google.com/file/d/1fdutyg9BU-kMVx-GcPrVckZ36fHAfAmn/view?usp=sharing', '_blank')">
L Amlo Launching Literature
</div>

</div>   
<footer>
    <p>© 2024 Md. Nurullah. All rights reserved.</p>
</footer>
<center><div class="ovalEnd">The End-L- Amlo</div></center><!--End Line----> 
</body>
</html>